SACCO, RODOLFO, COSMA, DAMIANO
 Distribuzione geografica
Continente #
NA - Nord America 1.637
EU - Europa 1.494
AS - Asia 596
Continente sconosciuto - Info sul continente non disponibili 11
OC - Oceania 2
SA - Sud America 1
Totale 3.741
Nazione #
US - Stati Uniti d'America 1.629
IE - Irlanda 514
CN - Cina 353
UA - Ucraina 314
SE - Svezia 309
IT - Italia 106
IN - India 86
VN - Vietnam 76
FI - Finlandia 71
GB - Regno Unito 63
TR - Turchia 59
DE - Germania 54
FR - Francia 30
BE - Belgio 16
EU - Europa 11
TW - Taiwan 9
CA - Canada 7
RO - Romania 6
RU - Federazione Russa 6
PH - Filippine 4
HK - Hong Kong 2
IR - Iran 2
KR - Corea 2
AL - Albania 1
AU - Australia 1
BR - Brasile 1
CH - Svizzera 1
ES - Italia 1
GR - Grecia 1
JP - Giappone 1
KY - Cayman, isole 1
NL - Olanda 1
NZ - Nuova Zelanda 1
SG - Singapore 1
TH - Thailandia 1
Totale 3.741
Città #
Dublin 514
Chandler 323
Jacksonville 220
Nyköping 195
Dearborn 148
Nanjing 114
Wilmington 93
Dong Ket 75
Ann Arbor 65
San Mateo 54
Beijing 53
Princeton 53
Woodbridge 50
New York 46
Nanchang 38
Ashburn 37
Boardman 30
Helsinki 28
Philadelphia 27
Cedar Knolls 23
Shenyang 23
Tianjin 20
Stevenage 19
Changsha 17
Brussels 16
Hebei 16
Jiaxing 16
Des Moines 13
Kunming 13
Hilden 12
Banqiao 9
Foggia 8
Hangzhou 8
Changchun 6
Kocaeli 6
Milan 6
Ningbo 6
Auburn Hills 5
Borås 5
Leawood 5
Los Angeles 5
Toronto 5
Augusta 4
Bari 4
Cluj 4
Fairfield 4
Guangzhou 4
Houston 4
Jinan 4
Pune 4
Seattle 4
Taizhou 4
Zhengzhou 4
Lanzhou 3
Las Vegas 3
Orange 3
Quezon City 3
Rome 3
Trani 3
Catania 2
Duncan 2
Genova 2
Hanover 2
Hartlepool 2
Hong Kong 2
Milnthorpe 2
Norwalk 2
Pisa 2
Redwood City 2
Rockville 2
Seoul 2
Shanghai 2
Southend 2
Washington 2
Auckland 1
Bangkok 1
Barrie 1
Birmingham 1
Blandford Forum 1
Bologna 1
Bothell 1
Bradford 1
Buffalo 1
Caivano 1
Caserta 1
Chalandri 1
Como 1
Council Bluffs 1
Dalmine 1
Den Haag 1
Frankfurt Am Main 1
Frankfurt am Main 1
George Town 1
Hirado 1
Ho Chi Minh City 1
Kolkata 1
Makati City 1
Melbourne 1
Messina 1
Minerbio 1
Totale 2.543
Nome #
Chemioembolizzazione con particelle embolizzanti a rilascio farmacologico (DEB-TACE) vs tecnica convenzionale (TACE): risposta tumorale e sopravvivenza in pazienti con HCC 212
228 CONVENTIONAL TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION (C-TACE) VERSUS DOXORUBICIN ELUTING BEAD (DEB)-TACE FOR HEPATOCELLULAR CARCINOMA: ASSESSMENT OF CLINICAL IMPACT-SHORT AND LONG-TERM PROSPECTIVE STUDY 170
526 Liver stiffness measured by transient elastography. The influence of biochemical activity 109
504 HBV quasispecies selected during lamivudine treatment may contribute to adefovir dipivoxil resistance 107
392 HBeAg defective mutants in active/inactive anti-HBe positive HBV carriers: Possible role of pre-core initiation mutants 107
The tightly regulated inducible expression of the core protein of hepatitis C virus modulates Fas- and TNF alpha-mediated apoptosis in human liver cells 106
Transient elastography improves the management of CHB patients 98
[GLUTATHIONE IN THE TREATMENT OF CHRONIC FATTY LIVER DISEASES] 96
HBeAg defective mutants in active/inactive anti-HBe positive HBsAg carriers: possible role of pre-core initiation mutants 92
Cost effective prediction of sustained response to IFN Alfa-2B or PEG-IFN Alfa 2B plus Ribavirin computing infected cells dynamics by early ALT and HCV-RNA decline 90
Survival after transarterial chemoembolization in early-stage HCC patients excluded from liver transplantation: a prospective cohort study 86
Liver inflammation and acute respiratory distress syndrome in a patient receiving hepatitis B vaccine: a possible relationship? 85
Transforming growth factor beta1 and soluble Fas serum levels in hepatocellular carcinoma. 82
Antiapoptotic regulation by hepatitis C virus core protein through up-regulation of inhibitor of caspase-activated DNase. 82
Hepatitis C virus serotypes in haemodialysis patients in South-East Italy. 80
Liver stiffness measured by transient elastography: The influence of biochemical activity 79
Early prediction of sustained response in chronic hepatitis C patients treated with pegilated IFNs (A-2B or A-2A) plus ribavirin using a bio-mathematical model that describes the dynamics of infected cells 78
Selective transcatheter arterial chemoembolization for hepatocellular carcinoma: Evaluation of clinical impact-short and long-term prospective study 75
sICAM-1, sCD95 and sCD95L levels in chronic liver diseases of different etiology. 75
Entecavir for Hepatitis B Virus Flare Treatment in Patients with Crohn’s Disease 75
Emergence of hepatitis B virus quasispecies with lower susceptibility to nucleos(t)ide analogues during lamivudine treatment. 74
The prevalence of hepatitis C virus types in patients of the same geographic area, according to the source of infection and liver disease. 74
Pulmonary or otolaryngologic extraesophageal manifestations in patients with gastroesophageal reflux disease 74
Hepatitis C virus serotypes and sources of infection in patients with HCV-related chronic liver disease from one geographical area in southeast Italy. 73
EARLY AND COST EFFECTIVE PREDICTION OF TREATMENT OUTCOME WITH IFNA2B OR PEG-IFNA2B PLUS RIBAVIRIN COMPUTING INFECTED CELLS DYNAMICS BY ALT AND HCV-RNA DECLINE DURING THE FIRST MONTH 73
Hepatitis C virus-RNA, immunoglobulin M anti-HCV and risk factors in haemodialysis patients. 72
MONITORING LIVER STIFFNESS: A NEW TOOL TO MEASURE LIVER FIBROSIS DURING THERAPY 72
Monitoring liver elasticity: a new tool to measure liver fibrosis during therapy 68
Distribution of hepatitis C virus serotypes and duration of infection in HCV infected subjects from a geographical area in Southeast Italy. 67
Feasibility and safety of granulocytapheresis in Crohn’s disease: A prospective color study 67
Transient elastography: a new surrogate marker of liver fibrosis influenced by major changes of transaminases. 66
Clinical impact of selective transarterial chemoembolization on hepatocellular carcinoma: a cohort study 64
Conventional vs Doxorubicin Eluting Bead Transcatheter Chemoembolization for Hepatocellular Carcinoma. 63
Endotics system versus colonscopy for the detection of polyps a randomised trial 63
A new model of HBV infection dynamics shows a multiphasic decay of viral load and a short half-life of circulating virus in anti-HBe positive patients treated with lamivudine 61
Complete response for advanced liver cancer during sorafenib therapy: case report. 60
Quantitative Determination of Hepatitis C Core Antigen in Therapy Monitoring for Chronic Hepatitis C. 58
Adherence to AASLD guidelines in the real world of HCC in Italy preliminary results of a prospective study 56
Valutazione dell’impatto sulla funzionalità epatica della chemioembolizzazione in pazienti con epatocarcinoma tecnica convenzionale Versus particelle embolizzanti. 56
Endotics system vs colonoscopy for the detection of polyps 51
Efficacy of hemostatic powders in lower gastrointestinal bleeding: Clinical series and literature review 49
Efficacy of combined transarterial radioembolization and sorafenib in the treatment of hepatocarcinoma: A meta-analysis 45
Transarterial chemoembolization in very early and early-stage hepatocellular carcinoma patients excluded from curative treatment: A prospective cohort study. 44
Sustained response to Interferon-ribavirin combination therapy in chronich hepatitis C predicted by a model of viral dynamics using both HCV-RNA and alanine amino transferase. 43
Partial Response and Cardiovascular Recovery after Sorafenib Dose Reduction in a Multinodular HCC Patient. 42
Effectiveness of hemostatic powders in lower gastrointestinal bleeding: a systematic review and meta-analysis 41
Natural Progression of Non-Alcoholic Steatohepatitis to Hepatocellular Carcinoma 39
TRANS-TACE: Prognostic Role of the Transient Hypertransaminasemia after Conventional Chemoembolization for Hepatocellular Carcinoma 31
Stereotactic body radiotherapy vs radiofrequency ablation for the treatment of hepatocellular carcinoma: a meta-analysis 27
Microwave Ablation Versus Radiofrequency Ablation for Treatment of Hepatocellular Carcinoma: A Meta-Analysis of Randomized Controlled Trials 23
Utilization of Hepatocellular Carcinoma Surveillance Programs in Patients With Cirrhosis: A Systematic Review and Meta-Analysis 23
Role of Etiology in Hepatocellular Carcinoma Patients Treated with Lenvatinib: A Counterfactual Event-Based Mediation Analysis 21
Towards a tailored systemic therapy for liver cancer 21
Prognostic Role of Post-Induction Fecal Calprotectin Levels in Patients with Inflammatory Bowel Disease Treated with Biological Therapies 19
Target therapies plus somatostatin analogues in NETs: a network meta-analysis 19
Risk of Hepatocellular Carcinoma in Patients with Porphyria: A Systematic Review 16
Reply to Lissing et al. Comment on "Ramai et al. Risk of Hepatocellular Carcinoma in Patients with Porphyria: A Systematic Review. Cancers 2022, 14, 2947" 15
Cholangiocarcinoma in the Era of Immunotherapy 8
Totale 3.822
Categoria #
all - tutte 15.555
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.555


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201983 0 0 0 0 0 0 0 0 0 8 29 46
2019/2020650 139 73 19 20 74 84 80 7 62 13 63 16
2020/2021466 48 2 48 1 45 17 52 9 55 100 7 82
2021/2022365 53 4 9 8 54 25 16 21 47 37 7 84
2022/20231.416 116 79 82 112 71 124 6 133 620 10 40 23
2023/2024165 42 14 4 4 16 62 2 5 2 14 0 0
Totale 3.822